Attention Deficit / Hyperactivity Disorder (ADHD)
Atamax® is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in children from 6 years of age, in adolescents and in adults as part of a complete treatment program.
Treatment should be started by a specialist in the treatment of ADHD, such as paediatricians, child psychiatrists, or psychiatrists. Diagnosis should be made according to current DSM criteria or the guidelines included in ICD.
In adults, the presence of ADHD symptoms already in childhood should be confirmed. It would be desirable if they were corroborated by a third party and treatment with Atamax® should not be started when verification of ADHD symptoms in childhood is doubtful.
Download sheetAvailable in packs of:
